In this episode of 'Talking About Glaucoma,' host Rob Schertzer, a Vancouver-based glaucoma specialist, chats with guest Gavin Docherty about the evolving understanding of preservative-free therapies in glaucoma management. They discuss the historical rationale for including preservatives in eye drops and the recent studies showing that preservative-free options are equally effective while reducing side effects such as hyperemia, burning, and irritation. The conversation covers the benefits of preservative-free drops in terms of improving patient compliance and minimizing ocular surface damage, which could potentially lead to fewer surgeries and better outcomes. They also share clinical experiences and highlight the barriers to transitioning patients to preservative-free medications, including issues related to cost, accessibility, and environmental waste. The episode concludes with an emphasis on the importance of collaboration among eye care providers to enhance patient care.
All content for Talking About Glaucoma (mp3) is the property of Robert M Schertzer, MD, MEd, FRCSC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of 'Talking About Glaucoma,' host Rob Schertzer, a Vancouver-based glaucoma specialist, chats with guest Gavin Docherty about the evolving understanding of preservative-free therapies in glaucoma management. They discuss the historical rationale for including preservatives in eye drops and the recent studies showing that preservative-free options are equally effective while reducing side effects such as hyperemia, burning, and irritation. The conversation covers the benefits of preservative-free drops in terms of improving patient compliance and minimizing ocular surface damage, which could potentially lead to fewer surgeries and better outcomes. They also share clinical experiences and highlight the barriers to transitioning patients to preservative-free medications, including issues related to cost, accessibility, and environmental waste. The episode concludes with an emphasis on the importance of collaboration among eye care providers to enhance patient care.
Ep 29 Talking About Glaucoma - 29Jan2018 FELLMAN Fluid Wave (mp3)
Talking About Glaucoma (mp3)
19 minutes 35 seconds
7 years ago
Ep 29 Talking About Glaucoma - 29Jan2018 FELLMAN Fluid Wave (mp3)
I sat down with Ron Fellman at a recent American Glaucoma Society meeting to discuss the use of the fluid wave in assessing the aqueous humour outflow pathway and its clinical application.
Talking About Glaucoma (mp3)
In this episode of 'Talking About Glaucoma,' host Rob Schertzer, a Vancouver-based glaucoma specialist, chats with guest Gavin Docherty about the evolving understanding of preservative-free therapies in glaucoma management. They discuss the historical rationale for including preservatives in eye drops and the recent studies showing that preservative-free options are equally effective while reducing side effects such as hyperemia, burning, and irritation. The conversation covers the benefits of preservative-free drops in terms of improving patient compliance and minimizing ocular surface damage, which could potentially lead to fewer surgeries and better outcomes. They also share clinical experiences and highlight the barriers to transitioning patients to preservative-free medications, including issues related to cost, accessibility, and environmental waste. The episode concludes with an emphasis on the importance of collaboration among eye care providers to enhance patient care.
